32 results on '"Anti il 5"'
Search Results
2. Exacerbations of Severe Asthma While on Anti–IL-5 Biologics
3. Subcutaneous Mepolizumab Injection: An Adjunctive Treatment for Recalcitrant Allergic Fungal Rhinosinusitis Patients With Asthma
4. Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
5. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting
6. Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma
7. Cardiovascular adverse effects of anti-IL-5/IL-5Rα therapies: A real-world study
8. M173 SUCCESSFUL MANAGEMENT OF EOSINOPHILIC MYOCARDITIS IN A PATIENT WITH IDIOPATHIC HYPEREOSINOPHILIC SYNDROME WITH ANTI-IL-5 THERAPY
9. Mepolizumab use
10. Disparate Eosinophilic Phenotypes with Age: Impact on Eligibility for Anti-IL-5 Therapies in Severe Asthma
11. Controversies in Allergy: Should Severe Asthma with Eosinophilic Phenotype Always Be Treated with Anti-IL-5 Therapies
12. The effect of mepolizumab, an anti-IL-5 monoclonal antibody, on eosinophilic otitis media associated with severe asthma
13. Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions
14. Exhaled Nitric Oxide in Severe Asthmatics Receiving Anti-IL-5 Therapy
15. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis
16. Biologic and New Therapies in Asthma
17. Human(ized) monoclonal antibodies in atopic patients - state of the art
18. Use of biologicals as immunotherapy in asthma and related diseases
19. Mepolizumab in eosinophilic disorders
20. The Effect of Anti-IL-5 Therapy on Esophageal Mastocytosis in Pediatric Eosinophilic Esophagitis
21. Anti–IL-5 (mepolizumab) therapy does not alter IL-5 receptor α levels in patients with eosinophilic esophagitis
22. Mepolizumab, A Humanised Anti-IL-5 Monoclonal Antibody, As Treatment Of Severe Nasal Polyposis
23. Increased High Molecular Weight IL-5 Complex After Anti-IL-5 (Mepolizumab) Therapy
24. Humanized Anti-IL-5 Therapy (Mepolizumab) Reduces Eosinophil Responsiveness to the Eotaxins
25. Anti-IL-5 Therapy (Mepolizumab) in Hypereosinophilic Syndromes and Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood Eosinophilia
26. Sa.60. Anti-IL-5 Therapy (Mepolizumab) for Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood and Esophageal Eosinophilia
27. Sa.49. Anti-IL-5 Therapy (Mepolizumab) for Eosinophilic Esophagitis: Cytokine Secretion and Decreased Peripheral Blood and Esophageal Eosinophilia
28. Anti–IL-5 treatment improves airway remodeling in asthmatic individuals
29. Anti–IL-5 for hypereosinophilia
30. Pilot study of anti-IL-5 in eosinophilic gastroenteritis
31. Effect of intravenous administration of an anti-IL-5 mAb (Mepolizumab) on allergen-induced tissue eosinophilia, the late-phase allergic reaction and the expression of a marker of repair/remodeling in human atopic subjects
32. The trials and tribulations of anti–IL-5 …
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.